After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...

Back in November 2023, pharmaphorum travelled to Uppsala, Sweden, for a Novavax press conference, the company celebrating a decade of doing what it does best: vaccines. From COVID-19 to malaria ...

Both studies will evaluate the combination vaccines with different recombinant spike antigen levels of the Novavax COVID-19 vaccine ... and decreasing syringe and vial disposal requirements.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...

The Novavax COVID-19 vaccine, when used as a booster dose ... reduced errors and decreased syringe and vial disposal needs. This announcement follows the European Medicines Agency’s approval ...

"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important partnership with one of the world's leading vaccine companies," NVAX CEO John ...

Novavax shares are trading lower by 9.8% during Monday's session. Shares of vaccine stocks are trading lower after Moderna issued 2025 revenue guidance below analyst estimates. Novavax shares ...

Moderna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains. The average of price targets set by Wall Street analysts indicates a potential upside ...